BOLD.XXX News
Archived Headlines
- 5 IPOs set terms in most active day of 2016 07/12/16
- BOLD move for a biotech: Audentes Therapeutics sets terms for $75 million IPO 07/11/16
- US IPO Weekly Recap: The only IPO delays as the market falls for the second straight week 01/15/16
- US IPO Weekly Recap: 2016 IPO market kicks off with a flurry of biotech filings 01/08/16
- Genetic defect biotech Audentes files for a $86 million IPO 01/04/16
US IPO Weekly Recap: Three profitable companies deliver double-digit returns
Three profitable companies each traded up more than 20% this past week, while the sole biotech IPO ended flat. Radio-frequency chip maker Impinj, the week's smallest IPO, delivered the largest return (+40%). For 2016 IPOs, first-day returns (+9.0%) have now...read more
OrbiMed-backed Audentes Therapeutics prices IPO at $15, within the range
Audentes Therapeutics, a preclinical biotech developing gene therapies for rare diseases, raised $75 million by offering 5 million shares at $15, within the range of $14 to $16. Audentes Therapeutics plans to list on the Nasdaq under the symbol BOLD. BofA...read more
US IPO Week Ahead: Three profitable IPOs and a biotech look to raise $900 million
Four IPOs are on the calendar to raise nearly $900 million in the week ahead. Three are profitable, including the fourth-largest offering of 2016 and two companies that...read more
US IPO Weekly Recap: LINE and AdvancePierre trade up on market debut
All eyes were on Japanese messaging application LINE's (LN) highly anticipated debut this week; and it did not disappoint, popping 27% on its opening day. AdvancePierre Foods (APFH) raised $391 million and traded...read more